Abstract: A glove spraying apparatus and system, and a glove are disclosed. The glove spraying apparatus includes a first liquid container, a plurality of universal pipelines, and a plurality of nozzles. The first liquid container communicates with first ends of the universal pipelines through pipelines; the nozzles are fluidly connected to second ends of the universal pipelines. By mounting the nozzles at the second ends of the universal pipelines and communicating with the universal pipelines, the user may adjust the positions and orientations of the nozzles by means of the universal pipelines, thereby enabling spraying for different portions of the glove.

Abstract: Methods and pharmaceutical compositions for the treatment of choroidal neovascularisation are provided. In particular, a method of treating choroidal neovascularisation in a subject in need thereof comprising administering to the subject a therapeutically effective amount of a mineralocorticoid receptor antagonist is provided.

Abstract: The present disclosure relates to the technical field of glove processing, and in particular to a glove comprising a coating and a preparation method thereof. The glove has an inner surface for contact with skin of a subject's hand, the inner surface being provided with a coating comprising hyaluronic acid or its salt thereof, and glycerin. The glove comprising the coating, provided by the present disclosure, is effective in increasing the skin hydration of a wearer's hand; while the coating has a simple preparation process with raw materials readily available, which is suitable for industrial production.

Abstract: A system including a data-driven controller configured to output signals controlling a dose of therapy to a treatment site and in response to feedback comprising data representing a healing state of the treatment site measured by a sensor; and a pumping system coupled to the controller, the pumping system pumping the therapy to the treatment site.

Abstract: Ocular Rosacea (OR) is a chronic inflammatory and neurovascular diseases of the ocular surface and eyelids. associated with abnormal tear film lipids that can lead to corneal neovascularization, loss of transparency and ulceration. Here, the inventors show that the combination of mineralocorticoid receptor blockade in association with local ocular glucocorticoids that have high GR binding affinity, have superior effects as compared to MR blockade alone, without the side effects of glucocorticoids on corneal wound healing. The combination of MR antagonist and low dose of a GR activator further reduces corneal edema, corneal neovascularization and improves corneal wound healing. The combination of MR antagonist and triamcinolone that has a strong GR binding affinity reinforces the beneficial effects of MR antagonists.

Abstract: This invention relates to the treatment of macular edema. Macular edema is the main cause of vision loss during diabetic macular edema, wet AMD (Age Related Macular Degeneration), retinal vein occlusion and chronic intraocular inflammation. Currently, beyond photocoagulation by laser irradiation, two types of drugs are used, protein molecules that neutralize VEGF family members and glucocorticoids, with different mechanisms of action, but targeting one single symptom: macular edema. The inventors have now found that macular edema may be treated by increasing the oncotic pressure of the vitreous. According to the inventors' understanding, causing an increase in the oncotic pressure of the vitreous induces a liquid flow from the interstitial water accumulated in the retina tissue to the vitreous compartment, so as to reduce or stop macular edema.

Abstract: This disclosure relates to a biodegradable core-shell microcapsule that includes (a) a shell containing the reaction product of an isocyanate-functionalized prepolymer with a crosslinker and optionally a polyelectrolyte under an aqueous condition, and (b) a core containing an active material, wherein the isocyanate-functionalized prepolymer is the reaction product of a polyisocyanate with a biopolymer and/or an amphiphilic compound under an anhydrous condition, and the microcapsule shell is substantially free of or free of a self-condensed polyisocyanate. This disclosure also relates to a process of preparing such biodegradable core-shell microcapsule. This disclosure also relates to a consumer product containing such biodegradable core-shell microcapsule. This disclosure also relates to a process of making the isocyanate-functionalized prepolymer.

Abstract: A spoiling apparatus for triggering a turbulent transition by autonomous disturbance and spoilers. The spoilers are mounted in multiple grooves in the circumferential direction of a navigating body, when a flow autonomously undergoes a turbulent transition, the spoilers remain in the grooves, the surface of the navigating body is free of protrusion, thus causing no additional flow resistance. A rated critical Reynolds number is set, in a case of a reduced flow speed and reduced density, the flow is a laminar flow, at which time the pressure applied to the spoilers by the flow is reduced, and the spoilers are ejected under the effect of compression springs. When ejected, the spoilers disturb the flowing of the bottom layer of the flow, and trigger the laminar flow into a turbulent flow.

Abstract: Method, computer program product, and computer system are provided. A plurality of query activities are captured from one or more monitored databases. The query activities are persisted into a graph-enabled database repository. The plurality of query activities are classified into a plurality of workload rules based on there being a correlations between the plurality of query activities. A plurality of components of a total execution time of each query in a workload rule is analyzed. One or more problematic queries is identified based on the analyzing.

Abstract: This invention relates to the treatment of macular edema. Macular edema is the main cause of vision loss during diabetic macular edema, wet AMD (Age Related Macular Degeneration), retinal vein occlusion and chronic intraocular inflammation. Currently, beyond photocoagulation by laser irradiation, two types of drugs are used, protein molecules that neutralize VEGF family members and glucocorticoids, with different mechanisms of action, but targeting one single symptom: macular edema. The inventors have now found that macular edema may be treated by increasing the oncotic pressure of the vitreous. According to the inventors' understanding, causing an increase in the oncotic pressure of the vitreous induces a liquid flow from the interstitial water accumulated in the retina tissue to the vitreous compartment, so as to reduce or stop macular edema.

Abstract: Disclosed are a clutch mechanism, a steering system, and an automobile. The clutch mechanism includes a slidable block and a driving component. The slidable block can be accommodated in a radial spacing between a first end shaft and a second end shaft that are coaxially arranged and radially spaced apart from each other, and is configured to translate along an axial direction of the first end shaft and the second end shaft to realize decoupling or coupling between the first end shaft and the second end shaft. The driving component is configured to drive the slidable block to translate along the axial direction of the first end shaft and the second end shaft.

Abstract: A clutch device, includes: a first transmission member and a second transmission member, the first transmission member is configured to move between a jointed position and a disjointed position, when the first transmission member is in the jointed position, the first transmission member is jointed with the second transmission member to transfer torque, and when the first transmission member is in the disjointed position, the first transmission member is disjointed from the second transmission member to stop transferring the torque; and a driving mechanism, including a driving device and a driven member and connected with the driving device and the first transmission member in transmission, the driving device drives the driven member to move to drive the first transmission member to move between the jointed position and the disjointed position, and a direction of movement of the driven member is parallel to a direction of movement of the first transmission member.

Abstract: A path protection method includes receiving, by a source node of a first path, a path event notify message from a first node on the first path. The path event notify message includes indication information that the first path is predicted to fail. The path protection method further includes obtaining, by the source node, information about a predicted protection path. The information about the predicted protection path includes resource information of a second path useable to protect a service on the first path. The first path and the second path include the source node and a same sink node. The path protection method further includes storing, by the source node, the resource information of the second path.

Abstract: A coal-air synchronous dynamic coordinated control method for a coal-fired unit is provided, comprising: determining functional relationship between unit loads and designed coal feed rates and functional relationship between unit loads and flue gas operation wet-basis oxygen contents, respectively; obtaining a theoretical wet flue gas volume and a combustion-supporting dry air volume per unit mass of burning coal, and calculating an actual combustion-supporting dry air volume per unit mass of burning coal; calculating an actual low calorific value of feed coal; calculating a combustion-supporting dry air volume and an outlet wet flue gas volume; according to the target value of load instruction at a future time point, calculating a coal feed rate variation and a combustion-supporting dry air volume variation; obtaining an operation wet-basis oxygen content variation; and obtaining target values of the coal feed rate and the operation wet-basis oxygen content to be adjusted.

Abstract: A semantic classification model training method includes that a sample query template and a label category of at least one category to be predicted in the sample query template are acquired, where the sample query template is constructed according to a sample query statement and a number of the at least one category to be predicted; the sample query template is input to the pre-constructed semantic classification model to obtain a sample semantic category of the at least one category to be predicted; and the semantic classification model is trained according to the sample semantic category and the label category of the at least one category to be predicted.

Abstract: A steering system includes: a steering gear body, where the steering gear body includes a steering gear input shaft and a gear shaft; a decoupling mechanism, where the decoupling mechanism is configured to decouple the steering gear input shaft from the gear shaft or couple the steering gear input shaft to the gear shaft; and a limiting mechanism, where the limiting mechanism is configured to limit a range of a steering angle of the steering gear input shaft, in response to that the steering gear input shaft is decoupled from the gear shaft or that the steering gear input shaft is coupled to the gear shaft.

Abstract: This application provides a node configuration method, wherein the method includes: First, determinning a target network based on an original network, where the original network is for flooding control topology information, the target network is for flooding the service topology information, and a quantity of flooding paths in the target network is less than a quantity of flooding paths in the original network. Next, determinning attributes of all interfaces on each node, where the attributes of the interfaces include a first attribute and a second attribute, an interface with the first attribute is configured to flood the service topology information. Further, generating first configuration information based on the attributes of all the interfaces on each node, and sends, to each node, the first configuration information corresponding to each node, where the first configuration information indicates each node to configure the attributes of all the local interfaces.

Abstract: A coal-air synchronous dynamic coordinated control method for a coal-fired unit is provided, comprising: determining functional relationship between unit loads and designed coal feed rates and functional relationship between unit loads and flue gas operation wet-basis oxygen contents, respectively; obtaining a theoretical wet flue gas volume and a combustion-supporting dry air volume per unit mass of burning coal, and calculating an actual combustion-supporting dry air volume per unit mass of burning coal; calculating an actual low calorific value of feed coal; calculating a combustion-supporting dry air volume and an outlet wet flue gas volume; according to the target value of load instruction at a future time point, calculating a coal feed rate variation and a combustion-supporting dry air volume variation; obtaining an operation wet-basis oxygen content variation; and obtaining target values of the coal feed rate and the operation wet-basis oxygen content to be adjusted.

Abstract: Central Serous chorioretinopathy (CSCR) is primarily an ocular disease, affecting the choroid and the retinal pigment epithelium. To date, no systemic biomarker of CSCR have been discovered that could link both forms and help the diagnosis in challenging cases. In the present invention, the inventors measure in European cohorts of CSCR patients (n=168) with (n=90) or without epitheliopathy (n=78) and a cohort of 153 control subjects without any ocular disease history, the serum levels of NGAL and the NGAL/MMP9 complex. Serum NGAL (ng/ml) was significantly higher in the control group (108.8±46.8) than in the CSCR cohort (80.4±46.4, p<0.0001). Serum NGAL (ng/ml) was significantly lower in the acute/recurrent cohort (n=78, 71.3±32.1) than in the control and, than in the chronic cohort (n=90, 88.3±55, p=0.03). Similarly, Serum NGAL/MMP9 (ng/ml) levels was lower in the whole CSCR cohort (44.5±39.6) as compared to the controls (77.6±47.8, p<0.0001).